Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources


News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 151-175 out of 911.

<< < 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 > >>

Public Release: 13-Jun-2016
Nature Cell Biology
Reclaiming the immune system's assault on tumors
One of the major obstacles with treating cancer is that tumors can conscript the body's immune cells and make them work for them. Researchers at EPFL have now found a way to reclaim the corrupted immune cells, turn them into signals for the immune system to attack the tumor, and even prevent metastasis.
Swiss National Science Foundation, Fondation pour la lutte contre le cancer, Swiss Federal Commission for Scholarships for Foreign Students, F. Hoffmann-La Roche AG

Contact: Nik Papageorgiou
Ecole Polytechnique Fédérale de Lausanne

Public Release: 10-Jun-2016
International Journal of Cancer
Cancer-causing virus strikes genetically vulnerable horses
A new study shows genetic differences in immune function partly account for why some horses get sarcoid tumors while others do not.
Morris Animal Foundation

Contact: Merry Buckley
Cornell University, College of Veterinary Medicine

Public Release: 10-Jun-2016
New tool brings personalized medicine closer
Scientists from EPFL and ETHZ have developed a powerful tool for exploring and determining the inherent biological differences between individuals, which overcomes a major hurdle for personalized medicine.
École Polytechnique Fédérale de Lausanne, ETH Zurich, European Research Council, Swiss Initiative for Systems Biology, Swiss National Science Foundation, National Institutes of Health

Contact: Nik Papageorgiou
Ecole Polytechnique Fédérale de Lausanne

Public Release: 9-Jun-2016
A new Biodiversity Portal for Europe to enhance access to monitoring data
Set to compile the largest biodiversity data collection for Europe to date, the EU-funded FP7 project EU BON has now launched the beta version of its European Biodiversity Portal.

Contact: Dr. Hannu Saarenmaa
Pensoft Publishers

Public Release: 9-Jun-2016
Stem Cell Reports
Study sets standards for evaluating pluripotent stem cell quality
As the promise of using regenerative stem cell therapies draws closer, a consortium of biomedical scientists reports about 30 percent of induced pluripotent stem cells they analyzed from 10 research institutions were genetically unstable and not safe for clinical use. In a study published June 9 by the journal Stem Cell Reports, the multi-institutional research team reports on the comprehensive characterization of a large set of induced pluripotent stem cells (iPSCs).

Contact: Nick Miller
Cincinnati Children's Hospital Medical Center

Public Release: 8-Jun-2016
Environmental Genomics
How 'super organisms' evolve in response to toxic environments
Scientists have long known that many diseases have a strong genetic component, but they are only recently paying more attention to the role played by the relationship between genetics and the environment. The study of how genetic function is influenced by manmade environmental stress at a population level is the subject of a course entitled "Environmental Genomics" to be held at the MDI Biological Laboratory in Bar Harbor, Maine, July 30 through Aug. 6.
National Instutes of Health, Big Data to Knowledge

Contact: Stefanie Matteson
Mount Desert Island Biological Laboratory

Public Release: 8-Jun-2016
Journal of The Royal Society Interface
Slime mold gives insight into the intelligence of neuron-less organisms
How do organisms without brains make decisions? Most of life is brainless and the vast majority of organisms on Earth lack neurons altogether. Plants, fungi and bacteria must all cope with the same problem as humans -- to make the best choices in a complex and ever-changing world or risk dying - without the help of a simple nervous system in many cases.

Contact: Tanya Klein
New Jersey Institute of Technology

Public Release: 8-Jun-2016
Faster, better, cheaper tests for blood disease
Researchers and clinicians from hospitals and universities in the UK and other countries have collaborated to better understand diseases of platelets -- the little cells that help blood to clot. They have developed a more effective, comprehensive and cheaper panel of genetic tests that are already being used to benefit patients in the UK National Health Service. The new test scans almost 80 genes in parallel.
National Institute for Health Research and others

Contact: Don Powell
Don Powell Associates Ltd

Public Release: 8-Jun-2016
Cell Systems
What makes a small worm a popular model
Researchers from the Friedrich Schiller University Jena and Kiel University (Germany) have compiled all metabolic pathways of the model organism Caenorhabditis elegans described so far and have presented a comprehensive metabolic model in the current edition of the journal 'Cell Systems'. The model, called 'ElegCyc', covers about 2,000 metabolic processes and is available to research groups all over the world.

Contact: Ute Schoenfelder
Friedrich-Schiller-Universitaet Jena

Public Release: 8-Jun-2016
New England Journal of Medicine
Sanger Institute: Landmark study shows AML is at least 11 different diseases
Patients with acute myeloid leukemia (AML) could be separated genomically into at least 11 major groups, each with different constellations of genetic changes and distinctive clinical features. This genetic complexity helps explain why AML shows such variability in survival rates among patients. Full knowledge of the genetic make-up of a patient's leukemia substantially improved the ability to predict whether that patient would be cured with current treatments.
Wellcome Trust, Bundesministerium fur Bildungund Forschung, Deutsche Krebshilfe, Deutsche Forschungsgemeinschaft, European Hematology Association, Amgen, Kay Kendall Leukaemia Fund

Contact: Sam Wynne
Wellcome Trust Sanger Institute

Public Release: 7-Jun-2016
Microbial Cell Factories
A new molecular toolkit for the de-novo design of bioactive agents
Scientists at the Technical University of Munich take a new approach to the production of bioactive natural substances: Using synthetic biotechnology methodologies they have developed a biochemical strategy to synthesize medical agents by a templated enzyme design process. First products, a precursor of the anti-cancer medicament Taxol, anti-inflammatory substances and omega-3 fatty acids prove the successfulness of their strategy.
European Union, German Federal Ministry of Education and Research, German Federal Ministry of Economics, State of Bavaria

Contact: Dr. Andreas Battenberg
Technical University of Munich (TUM)

Public Release: 7-Jun-2016
Comparative and Experimental Approaches to Aging Biology Research
MDI Biological Laboratory to offer new signature course on aging
Why do we age? What are the mechanisms that regulate aging on a cellular level? Is it possible to extend youthfulness through genetic manipulation? These are some of the tantalizing questions that will be the subject of a new signature course on aging to be held at the MDI Biological Laboratory, in Bar Harbor, Maine, from June 19 through July 3.
Glenn Foundation for Medical Research

Contact: Stefanie Matteson
Mount Desert Island Biological Laboratory

Public Release: 6-Jun-2016
Genomic Data Commons at University of Chicago launches new era of cancer data sharing
The Genomic Data Commons, a next-generation platform that enables unprecedented data access, analysis and sharing for cancer research, publicly launched at the University of Chicago on June 6, opening the door to discoveries for this complex set of diseases.
NIH/National Cancer Institute

Contact: Kevin Jiang
University of Chicago Medical Center

Public Release: 6-Jun-2016
Proceedings of the National Academy of Sciences
Distinguishing deadly Staph bacteria from harmless strains
To better understand the pathogenic bacteria Staphylococcus aureus and develop more effective treatments, University of California San Diego researchers examined the Staph 'pan-genome' -- the genomes of 64 different strains that differ in where they live, the types of hosts they infect and their antibiotic resistance profiles. This effort, published June 6 by PNAS, places all Staph genes into one of two categories: the core genome or the dispensable genome.
National Institutes of Health

Contact: Heather Buschman
University of California - San Diego

Public Release: 6-Jun-2016
Proceedings of the National Academy of Sciences
Eddies enhance survival of coral reef fish in sub-tropical waters
Swirling eddies in the ocean have long been thought to be beneficial to organisms such as larval fishes residing within them because of enhanced phytoplankton production. However, direct evidence for this hypothesis has been hard to come by. A new study confirms the critical role of these oceanographic features.

Contact: Su Sponaugle
Oregon State University

Public Release: 3-Jun-2016
BluePen Biomarkers announces collaboration with the University of Pennsylvania
The University of Pennsylvania has co-founded and structured BluePen Biomarkers in collaboration with BluePrint Bio, Inc. and Emerald Logic, Inc. to conduct biomarker research and identification. BluePen is creating a comprehensive biomarker measurement and discovery pipeline for the acceleration of personalized medicine.

Contact: Evan Lerner
University of Pennsylvania

Public Release: 2-Jun-2016
Stampede 2 drives the frontiers of science and engineering forward
The National Science Foundation announced a $30 million award to the Texas Advanced Computing Center at The University of Texas at Austin to acquire and deploy a new large scale supercomputing system, Stampede 2, as a strategic national resource to provide high-performance computing capabilities for thousands of researchers across the US.
National Science Foundation

Contact: Faith Singer-Villalobos
University of Texas at Austin, Texas Advanced Computing Center

Public Release: 2-Jun-2016
American Gut Project expands to Asia
University of California San Diego School of Medicine researchers are expanding the American Gut Project into Asia. The goal of American Gut, the world's largest crowdfunded citizen science project, is to sequence as many human microbiomes -- the unique collection of bacteria and other microbes that live in and on us -- as possible.

Contact: Heather Buschman
University of California - San Diego

Public Release: 2-Jun-2016
Nucleic Acids Research
New free web service for deep study of cell functions
Scientists from Russia, US, Canada and Germany have developed a simple and effective web service that enables a better understanding of cell functions by identifying links between changes in metabolism and gene expression. New insights gained by means of the service can be applied to develop treatments for autoimmune diseases and cancer, since metabolic regulation plays a major role in such biological processes.
Government of Russian Federation, Washington University in St. Louis

Contact: Dmitry Malkov
ITMO University

Public Release: 2-Jun-2016
Reading between the genes
For a long time dismissed as 'junk DNA,' we now know that also the regions between the genes fulfill vital functions. Scientists around Julien Gagneur, Professor for Computational Biology at the Technical University of Munich and Professor Patrick Cramer at the Max Planck Institute for Biophysical Chemistry in Göttingen have now developed a method to find regulatory DNA regions which are active and controlling genes.

Contact: Stefanie Reiffert
Technical University of Munich (TUM)

Public Release: 2-Jun-2016
Scientific Reports
Unusual combo reduces health risk from atypical antipsychotic
Data mining study shows that taking vitamin D ameliorates the risk of developing new-onset diabetes from atypical antipsychotics like quetiapine.
Japanese Society for the Promotion of Science

Contact: Anna Ikarashi
Kyoto University

Public Release: 2-Jun-2016
We've got tapeworms and scabies! And reproducible research
Two new research papers on scabies and tapeworms published in the Open Access journal GigaScience also include a collaboration with This collaboration showcases a new way to share scientific methods that allows scientists to better repeat and build on these complicated studies on difficult-to-study parasites. It also highlights a new means of writing all research papers with citable methods that can be updated over time. Keeping work clear, consistent, and current.

Contact: Scott Edmunds

Public Release: 2-Jun-2016
PLOS Biology
IU-led brain study suggests new ways to protect against neurodegeneration
A study published June 2 in the journal PLOS Biology led by biomedical researchers at Indiana University has found evidence that an enzyme known as NMNAT2 may help protect against the debilitating effects of certain degenerative brain diseases, including Alzheimer's.
National Institutes of Health

Contact: Kevin D. Fryling
Indiana University

Public Release: 1-Jun-2016
PLOS Neglected Tropical Diseases
TGen studies global fungal threat; finds six new species associated with bat evolution
A fungal infection associated with a high percentage of deaths among HIV and other immune-compromised patients is more diverse than previously known and likely spread around the world by bats. A global assessment of the fungus Histoplasma by the Translational Genomics Research Institute (TGen) found that the pathogen is divided among six species, and its spread and speciation from continent-to-continent over the past 9 million years coincides with the global dispersal and evolution of bats.

Contact: Steve Yozwiak
The Translational Genomics Research Institute

Public Release: 1-Jun-2016
ASSAY and Drug Development Technologies
Discovery of new IRAP inhibitors to improve cognitive functions
Researchers have discovered three new inhibitors of insulin-regulated aminopeptidase (IRAP), compounds shown to improve cognitive functions in animal models of human disorders. The new inhibitors are able to block human IRAP at low concentrations with rapid reversibility, as described in a study published in ASSAY and Drug Development Technologies.

Contact: Kathryn Ryan
Mary Ann Liebert, Inc./Genetic Engineering News

Showing releases 151-175 out of 911.

<< < 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 > >>